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ABSTRACT - Multiple sclerosis (MS) is a common disease in Western countries of temperate/cold climate, but
in tropical countries an increasing number of cases have been diagnosticated. Moved by the lack of information
about cognitive dysfunction of Brazilian MS patients, the present study attempted to describe features of
neuropsychological alterations in patients with relapsing remitting MS living in the city of São Paulo. They were
compared to healthy volunteers, matched for age and education. In the absence of global intellectual deterioration,
the patients had a deficit: a) in learning and verbal long-term memory tasks and in visual long-term memory of
complex figure; b) in timed tasks, accounted for by a slowness of mental processes; c) in tasks with a motor
component. Tendency to depression was observed; anxiety levels were normal.
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Perfil cognitivo de pacientes com esclerose múltipla do tipo surto-remissão
RESUMO - A esclerose múltipla (EM) é doença comum em países de clima temperado/frio, mas também em
países tropicais um crescente número de casos tem sido diagnosticado. Motivado pela escassez de informações
acerca da cognição dos portadores de EM em nosso país, o presente estudo procurou traçar o perfil neuropsicológico
de pacientes com EM da forma surto-remissão, residentes no município de São Paulo, os quais foram comparados
a pessoas sadias, com idade e escolaridade semelhantes. A inteligência geral dos pacientes estava preservada
mas foram detectados déficits: a) em tarefas de aprendizagem e de memória verbal e visual de figura complexa,
ambas de longo prazo; b) em tarefas cronometradas, explicados por lentificação do processamento mental; c) em
tarefas com componente motor. Tendência a depressão foi observada; os níveis de ansiedade encontravam-se
normais.
PALAVRAS-CHAVE: esclerose múltipla, surto-remissão, avaliação neuropsicológica, memória, cognição.
Multiple sclerosis (MS), also referred to in the British Commonwealth as disseminated sclerosis
and among French-speaking physicians as sclérose en plaques, is one of the most chronic neurologic
diseases1. Diagnosis may be uncertain in the early stages of the disease, although the combination of
(1) symptoms referable to white matter fiber tracts in optic nerves, brainstem and spinal cord, (2) a
multiplicity of lesions, and (3) temporal dispersion of attacks eventually makes the diagnosis certain.
According to clinical course, relapsing remitting (patients have a series of exacerbations of the
disease with complete or partial remission) and steadily progressive (patients have progressive
downhill course) are the two more frequent forms of presentation.
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The etiology of MS remains unknown, no cure is presently at hand and the prevalence is
high. In many regions of several countries of Europe and North America the distribution of MS is
high (prevalence of 30 or more per 100,000 population), with the prevalence increasing with increasing
latitude2. In tropical countries as Brazil, recent studies have estimated a prevalence of 4.27 cases per
100,000 population in the City of São Paulo3, meaning that we are in a low frequency zone (less than
5 per 100,000), although this figure can change with new surveys. The standardization of diagnostic
criteria carried out by Poser and collaborators4 and the general acceptance of the disability scale
proposed by Kurtzke5 have constituted fundamental steps to promote the advancement of research
in this area. Comparative studies using these international standards and aimed at elucidating the
clinical profile and the evolutive course of the disease in countries of the southern hemisphere are
being carried out. One interesting question have to do with possible differences or the lack of them
in the manifestations of MS in tropical climate regions as compared to temperate and cold regions6,7.
It has often been pointed out that patients with MS, mainly in late stages, have decreased
cognitive capacities, related to size and site of the plaques. These cognitive alterations, however,
may appear also in mild stages8,9. This cognitive impoverishment was already registered by Charcot
in the 19th century9, but systematic cognitive studies have begun only recently. Memory and learning
impairments are being repeatedly demonstrated since the late 60s (e.g.9-14), while general intelligence
and language seem to be less affected.
While a wealth of data concerning a variety of neuropsychological aspects of MS patients is
continuously being gathered in northern countries (for reviews:9,15,16), in South American countries
neuropsychological data are very scarce. Aiming to contribute to the partial filling of this gap, the
present study attempted to describe a cognitive profile of relapsing remitting MS patients living in
the City of São Paulo, SP and under treatment in a public hospital of this city.
METHOD
Participants
The participants were 25 patients with clinically definite MS, as diagnosed by the criteria of Poser et al.4
and classified as having the relapsing remitting course of the disease. Further criteria of inclusion were: at least
4 years of formal education, 18-60 years of age, no history of other psychiatric or neurologic disease, no history
of alcohol or drug abuse, no other complicating medical condition. All the patients were physically independent,
with scores between 0-6 in the Expanded Disability Status Scale (EDSS)5. No patient with lesions limited only to
spinal cord was included. At the time of evaluation the disease was in a clinically inactive state. The first relapse
of most patients occurred in the second or third decade of life; only one patient had the first relapse after 50 years
of age. The average number of relapses was 3 in 8 years of disease. The patients (76% females) were volunteers
recruited among patients under treatment in the Department of Neurology of UNIFESP/Hospital São Paulo or
from the Associação Brasileira de Esclerose Múltipla (ABEM). All the patients were receiving symptomatic
medication, either interferon-beta 1b (on alternate days), azathioprine or methotrexate. Steroids were only
prescribed to treat acute relapses of the disease.
The control group consisted of 24 volunteers (75% females) who fulfilled the same basic criteria for
inclusion except the disease. Table 1 presents the distribution of age and education of both groups and also shows
the occupational status of the participants . As the disease progressed, the occupational status of many patients
changed, as they became unemployed, retired or stopped studying.
Neuropsychological evaluation
The procedures and consent form used in this study were approved by the Medical Ethics Committee of
the Universidade Federal de São Paulo.
The neuropsicological battery employed aimed to briefly investigate the main cognitive functions using
tests already reported in the literature8,9 to make possible a comparison with international data. The choice of the
tests was done in order to compare performance of patients with control subjects in several cognitive domains:
general intelligence, memory (immediate and recent, verbal and non-verbal), perceptual and motor capacities,
some aspects of language, and mood. The tests were administered by two trained psychologists. The order of
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presentation of the tests was pseudo-ramdomized in order to prevent any distortion that might be caused by
fatigue; rest periods during the application sessions were allowed depending on the physical and emotional states
of the subjects. All of them appeared to be motivated to perform the cognitive tasks. The battery was applied in
three sessions of 2 hours each, and consisted of the following tests:
a) a shortened version of the Wechsler Adult Intelligence Scale-Revised (WAIS-R), which included 5
verbal and 4 non-verbal subtests: Comprehension, Arithmetic, Similarities, Vocabulary, Digit Span, Digit Symbol,
Picture Completion, Block Design, Picture Arrangement17.
b) three subtests of the Wechsler Memory Scale (WMS): Logical Memory, Visual Reproduction and
Associate Learning17.
Table 1. Demographic variables.
MS Patients (n=25) Control Subjects (n=24) t values p
Age in years mean (range) 38.5 (18 - 56) 35.3 (20-54)  1.093 0.28
Education in years mean (range) 12.4 (6-20)  13.9 (4-20)  1.216 0.23
Sex (males/females)  6/19  6/18
Duration of disease in years mean (range)  8.7 (1-20) -
Number of relapses  3.4 -
Marital status
Married 13 (52%)  10 (42%)
Single 9 (36%)  13 (54%)
Divorced/separated 3 (12%) -
Divorced/ remarried -  1 (4%)
Occupational status (before MS)
Managerial 9 (36%) -
Commercial 5 (20%) -
Technical 5 (20%) -
Housewife 5 (20%) -
Student 1 (4%) -
Occupational status (present)
Managerial 2 (8%)  6 (25%)
Commercial 3 (12%)  9 (37.5%)
Technical 3 (12%)  2 (8%)
Housewife 8 (32%)  3 (12.5%)
Student 1 (4%)  4 (17%)
Unemployed 3 (12%)
Retired 1 (4%)
Retired by illness 4 (16%) -
School
Attending at present 5 (20%)  11 (46%)
Stopped attending 20 (80%)  13 (54%)
MS, multiple sclerosis.
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c) Stroop Color Test. It is a measure of cognitive flexibility and focused attention. The Victoria version
was used 18.
d) Rey-Osterrieth Complex Figure. It evaluates the perceptual and motor capacities required to copy a
complex figure, and assess delayed visual memory through a recovery test 30 minutes later18.
e) Corsi Block-tapping Test. It evaluates the immediate memory span for visuospatial material17.
f) Word Fluency Test (FAS). It evaluates verbal fluency and access to lexicon18.
g) Naming and Memory for Objects. Procedure I - Incidental memory: the subject is asked to name 15
small objects of everyday use, presented one at a time. Immediately after he/she is asked to remember which
objects he /she has seen with no previous knowledge of the memory requirement. Procedure II - Intentional
memory: the same task using 15 different objects, except that the subject knows in advance that a retention test
will be done. Procedure III - Recognition test, 30 minutes later, of all objects presented among others not shown
before.
h) Beck Depression Inventory 19.
i) State-Trait Anxiety Inventory (STAI) 19,20.
The subjects of the present study had also participated in a related study to be reported separatedly in
which word free recall tests were administered, intermingled with the battery listed above.
The Student t test was used to analyse statistically the results. For differences considered to be statistically
significant (p<0.05), we also calculated the effect size, that expresses the degree to which two sample means
differ in terms of pooled standard deviations21. Conventionally, a medium effect size is about 50-79% of the
group standard deviation and a large effect size is 80% or more of the standard deviation. When appropriate,
some results were analysed by a 2-way ANOVA followed by the Tukey a posteriori test.
RESULTS
Table 2 shows cognitive test scores means, standard deviations, t values and probability values
derived from Student test comparisons. Effect size values of significant differences are also indicated.
These ranged from 0.68-0.76 (medium degree of separation between means) to 0.81-1.12 (large
degree of separation).
There were no significant differences between the MS patients and their controls regarding
Full scale IQ and Verbal IQ of the WAIS-R.
The MS patients showed normal performance in the span measures, in both digit span and
visuospatial span (Corsi block-tapping test). The backward digit span as well as the backward
visuospatial span also were not different from controls.
Significant differences were found in tests that involved a motor component, such as the
Performance IQ that encompasses the Picture Completion, the Picture Arrangement and the Digit
Symbol tests. In the delayed test of the Rey-Osterrieth Figure the patients’ performance was also
lower than that of the controls (the effect size indicated a medium degree of separation between the
means of both groups), but the copy of this figure was within the normal range.
Immediate and delayed visual reproduction is a visual drawing memory test in which no
differences were apparent between patients and their controls, nor there was any interaction group x
trial [F(1,45)=0.914; p=0.34], as revealed by a 2-way ANOVA [F(1,45)=2.68; p=0.1]. The trial
effect was significant [F(1,45)=40.96; p<0.001], reflecting the decay of performance in the delayed
test in both groups (Fig 1C).
Significant differences in tests that evaluate cognitive functions relatively uncontaminated with
a motor component were also found: FAS (medium degree of separation between means, according to
the effect size value), Stroop Color, Associate Learning (immediate and delayed), Logical Memory
(immediate and delayed; medium degree of separation of means). Incidental and intentional memory as
well as delayed recognition of concrete material (objects from daily usage) were normal.
A 2-way ANOVA was performed to verify if Associate Learning had occurred. It showed an
increasing learning curve for both groups [F(3,141)=230.67; p<0.0001], and no interaction between
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Table 2. Neuropsychological evaluation.
MS Patients (mean±sd) Control Subjects (mean±sd)  t values p
WAIS-R
Full Scale IQ 104.8 ± 17.0 111.1 ± 14.6 1.364 0.17
Verbal IQ 109.8 ± 17.0 110.8 ± 14.3 0.21 0.82
Vocabulary 9.2 ± 2.3 9.3 ± 2.2 0.155 0.90
Arithmetic 8.2 ± 3.3 8.9 ± 2.8 0.825 0.41
Similarities 10.2 ± 2.7 10.0 ± 2.5 0.319 0.75
Digit Span Forward 5.9 ± 1.4 6.5 ± 1.9 1.193 0. 23
Digit Span Backward 4.0 ± 1.3 4.4 ± 1.5 1.267 0.30
Comprehension 11.3 ± 3.0 10.9 ± 2.2 0.55 0.58
Performance IQ 96.4 ± 14.9 108.1 ± 15.9 2.596 0.01 d
Picture Completion 8.2 ± 2.4 9.5 ± 2.5 1.789 0.08
Picture Arrangement 7.5 ± 2.5 9.6 ± 2.6 2.812 0.007 f
Block Design 8.2 ± 2.0 8.6 ± 1.5 0.770 0.44
Digit Symbol 6.6 ± 2.5 9.3 ± 2.5 3.802 0.0004 i
CORSI BLOCK-TAPPING
Forward 5.0 ± 1.1 5.5 ± 1.0 1.713 0.09
Backward 4.4 ± 0.8 4.8 ± 0.8 1.367 0.17
FAS 32.2 ± 9.9 39.3 ± 9.3 2.6 0.01 c
Rey-Osterrieth
Copy 33.5 ± 4.5 35.6 ± 5.5 1.460  0.15
Delayed 15.5 ± 8.4 20.8 ± 6.9 2.395 0.02 b
WMS
Logical Memory Immediate 21.2 ± 6.8 26.3 ± 6.9 2.590 0.01 c
Logical Memory delayed 17.7 ± 8.3 22.8 ± 6.7 2.339 0.02 a
Visual Reproducion Immediate 30.6 ± 6.7 33.3 ± 6.3 1.438  0.15
Visual Reproducion delayed 22.8 ± 10.6 27.3 ± 8.5 1.615  0.11
Associate Learning
Trial I 2.7 ± 1.0 4.1 ± 1.5 4.045 0.0001j
Trial II 4.2 ± 1.2 5.5 ± 1.4 3.476 0.001 h
Trial III 5.0 ± 1.4 6.1 ± 1.3 2.986 0.004 e
Trial IV 7.2 ± 1.8 8.4 ± 1.7 2.433 0.01 b
Objects
Incidental 9.6 ± 2.3 10.6 ± 1.3 1.810 0.07
Intentional 8.9 ± 2.2 9.4 ± 2.6 1.658 0.10
Delayed Recognition 9.6 ± 1.0 9.9 ± 0.3 1.358 0.18
Stroop color test
Card I
Reading time 18.5 ± 7.1 13.8 ± 4.5 2.731 0.009 e
Errors 0.3 ± 0.7 0.1 ± 0.4 1.225 0.22
Card II
Reading time 19.9 ± 10.0 16.6 ± 3.8 2.017 0.50
Errors 0.2 ± 0.8 0.4 ± 0.2 1.171 0.24
Card III
Reading time 35.8 ± 14.2 26.7 ± 7.2 2.793 0.007 e
Errors 1.2 ± 1.6 0.5 ± 1.5 1.431 0.15
MS,  multiple sclerosis; WAIS-R, Wechsler Adult Inteligence Scale-Revised; IQ, Intelligence Quotient; WMS, Wechsler Memory
Scale.  Effect size values: a=0.68; b=0.69; c=0.74; d=0.76; e=0.81; f=0.82; g=0.85; h=1.0; i=1.08; j=1.12.
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groups and trials [F(1,141)=0.2499; p=0.86], indicating that the rate of learning was similar in both
groups, although the amount of learning of the controls was higher than that of the patients
[F(1,47)=13.34; p=0.0007] (Fig 1A).
Regarding the Logical Memory Test (Fig 1B), a 2-way ANOVA showed that in the second
trial the subjects remembered less words than in the first trial [F(1,47)=6.308; p=0.01]. There was
no group x trial interaction [F(1,47)=0.0006; p=0.98], indicating that the rate of forgetting was
similar in both groups, in spite of the fact that the patients remembered less fragments of the story
[F(1,47)=63.515; p<0.0001).
The number of errors in the Stroop Color test was not greater in the patients group than in the
controls group in none of the three cards that constitute the task, but the patients were significantly
slower in reading the words of Cards I and III.
As shown in Table 3, the patients showed a higher score on the Beck Scale than the controls.
The anxiety inventory did not reveal differences between the groups.
Fig 1. Number of items recalled in three subtests of the WMS: (A) acquisition trials and delayed recall of the
Associate Learning subtest; (B) immediate and delayed recall of the Logical Memory subtest; (C) immediate and
delayed reproduction of the Visual Reproduction subtest.
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DISCUSSION
The Digit Span test is widely used to measure verbal short-term memory and also evaluates
auditory attention17, while the blocks of Corsi do the same thing with visuospatial material. The results
here presented are in agreement with several reports of normal verbal and visuospatial span8,10,12-14,22-24.
The known sensorimotor disturbances presented by MS patients may cause marked
impairments on tasks that require motor responses11,14,25. Thus, disturbances in motor function could
explain the poorer performance of our MS patients in some tasks contaminated with motor
components, as the Digit Symbols and the Picture Arrangement tests. Impairment on these tests was
reported previously8,26,27. Nonetheless, motor disturbances cannot account for deficits in many other
tests. For instance, the score attained by our patients in the delayed Osterrieth-Rey Figure was low,
but the copy was as good as the controls. Thus, it is necessary to invoke further impairment in other
cognitive functions to explain the deficit in this delayed test.
The WAIS Similarities was found to be impaired by Klonoff et al.8 but not by others10,14.
Deficits in the WAIS Block Design are not commonly reported. To our knowledge, in this latter test
and in other tests of the WAIS battery, only Rao et al.28 have found significant differences in part of
their sample of MS patients.
Deficits in planning and organizational skills are generally associated with disorders in the
frontal systems. In our patients, the constructional ability, as evaluated by the copy of the Rey-
Osterrieth Figure was found to be within the normal limits; organizational, planning and copying
abilities were not loosed, although slowness had been observed in some cases. Backward span
requires additional mental processing and therefore can be considered a test of working memory, a
function believed to be related to executive frontal systems29. Both verbal and visuospatial backward
span were found to be normal. Thus, the executive frontal functions of our patients do not appear to
be affected by the disease. Nonetheless, evidence for frontal dysfunction was reported by some
authors based on the Wisconsin Card Sorting Test22,30, but Beatty and Monson31 interpreted the
results usually obtained in MS as a deficit in concept formation.
The Stroop test revealed that the patients were slower than the control subjects in reading the
words, a result that is in agreement with Jennekens-Schinkel et al.32 and van den Burg et al.34 who
obtained a similar result. Information processing speed assessed by different techiques was reported
by others to be lower as well in MS patients14,25,33.
Disorders in language functions were not detected by the Vocabulary subtest of the WAIS-R
and by object naming. Naming was also found to be undisturbed in previous reports32.33. Word
generation was unimpaired in one study32, but in the present study the patients produced a significantly
smaller number of words in the FAS test, in agreement with most published results that show that
Table 3.- Mood evaluation.
MS Patients Control Subjects t values p
(mean±sd) (mean±sd)
BECK 15.5 (± 11.3) 7.0 (± 6.1) 3.122 0.003 a
STAI
Trait 44.6 (± 3.5) 43.8 (± 4.9) 0.539 0.5
State 46.5 (± 4.2) 45.9 (± 4.9) 0.343 0.7
MS, multiple sclerosis; BECK, Beck Depression Inventory; STAI, State-Trait Anxiety Inventory. Effect size values: a=0.98.
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impaired verbal fluency is a common finding in MS patients 8,22,23,26,30. A deficit in word generation
can be due to a slowing in mental processes, as the test requires the subject to produce as many
words as possible within a fixed limit of time.
Immediate and delayed measures of Visual Reproduction were not significantly reduced in
our patients. Memory for concrete objects was not impaired at all. In contrast, performance on tests
that involve immediate and delayed verbal memory (Logical Memory and Paired Associate Learning)
was impaired. This pattern of results suggests a deficit specific to verbal memory and verbal learning.
Running counter to this hypothesis, the delayed recall of the Complex Figure of Rey-Osterrieth, a
nonverbal memory test, was also poorer in our MS group. No explanation is available at the time for
these discrepancies on memory measures, but one can speculate that the complexity of the task
constitutes an important factor in determining memory impairments in these patients, as the tasks
that were impaired, Logical Memory, Paired Associates and Rey-Osterrieth Figure seem to be the
more complex tests, either in the number of items to be remembered or in the structure of the test.
How do our results in long-term memory tests compare to results in similar tasks reported in
the international literature? The WMS Logical Memory and similar story recall tests are consistently
found to be impaired in patiens with MS12,13,23,28, as well as the difficult pairs and the delayed testing
of paired associates8,13,24,35. Visual reproduction was also found to be impaired by Rao et al.13 in
chronic progressive patients.
Depression appears with a high rate of occurrence in patients with MS36. As cognitive
impairment occurs in depressed patients, the cognitive impoverishment of patients with MS may be
related to the their depressive state. In our sample, the patients attained higher scores on the Beck
inventory than the controls, but their mean score of 15.5 ± 11.3 is not indicative of clinical depression19.
A similar result in relapsing remitting patients was also found by others33,37, who considered that the
depression found in their patients, although more pronounced than in normal people, cannot account
for their cognitive deficits. It may be concluded, then, that the results of the group as a whole cannot
be explained by depressive state, although it cannot be ruled out that depression had affected the
individual results of some patients. Anxiety, on the contrary, remained in the same levels attained by
the controls of our sample.
Changes in the professional life of the patients, reflecting probably in their financial status, had
occurred as the demographic data suggest (Table 1). It is clear that the disease has an impact on the lives
of the patients not restricted to their physical conditions, but also affecting their social functioning,
family relationships, employment conditions, and their psychic and cognitive conditions38.
In the absence of global intellectual deterioration, the patients presented a deficit in performing
several cognitive tests. The pattern of deficits seen in our MS relapsing remitting patients comprises:
a) impairment in verbal and visual memory and learning tasks; b) impairment in timed tasks, accounted
for by a slowness of mental processes; c) impairment in tasks with a motor component, explained, at
least partially, by a difficulty in perform motor responses. Some of these tasks, however, are also
timed (e.g. Digit Symbols), so the deficit may lie on the slowness of processing instead of on
impairment of motor functioning.
These results are similar to those obtained in neuropsychological studies of European and
North American countries. Although clearly impaired, the magnitude of the deficits can be classified
as moderate. Some authors, indeed, have found less severe impairments on cognitive tests of relapsing
remitting patients than in chronic progressive patients22,33, but the question whether the degree of
cognitive impairment depends or not on the type of course of disease is still a matter for debate. The
degree of cognitive impairment is variable but the incidence is high even in patients physically
independent. According to Rao and his colleagues28, some degree of cognitive impairment affects
about 54% to 65% of the patients.
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